Men with coronary artery disease who used phosphodiesterase-5 (PDE-5) inhibitors for erectile dysfunction had fewer adverse cardiovascular events than those taking the prostaglandin drug alprostadil ...

The study from Sweden found a substantial benefit for men taking the class of drugs that was discovered by accident when researchers were developing a treatment for angina 2 decades ago. A study from ...

Men with stable CAD who are being treated for erectile dysfunction (ED) have a lower risk of dying if their medication is a phosphodiesterase 5 (PDE5) inhibitor rather than alprostadil, observational ...

A 63-y-old man attended the erectile dysfunction clinic. He was initially treated with intracavernosal injection of 20 μg alprostadil (Viridal®). Due to the poor response he used intraurethral ...

Erectile dysfunction (ED) is the frequent inability to achieve or keep an erection long enough to have sex. ED is actually a pretty common condition. The chances of developing it tend to increase with ...

Although ED is common, you don’t have to live with it. Our urological specialists understand your hesitation and frustration. We offer a range of personalized treatments to help you achieve the sexual ...

Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...